Exhibit 2.
Atypical Antipsychotic Drug | Percent with use in 1996/1997 | Percent with use in 2004/2005 | Growth in use (2004/2005 / 1996/1997) |
---|---|---|---|
Clozapine | 3.9% (2.4) | 4.8% (2.9) | 21.7% |
Olanzapine | 12.1% (3.6) | 35.0% (6.2) | 189.9% |
Quetiapine | -- | 14.4% (4.6) | -- |
Risperidone | 12.9% (4.9) | 19.4% (4.6) | 51.2% |
Ziprasidone | -- | 10.1% (3.7) | -- |
Aripiprazole |
--
|
15.6% (4.4)
|
-- |
Any | 26.7% (6.6) | 75.2% (5.0) | 181.9% |
Percents reflect percentage of people reporting one or more filled prescriptions during the year (quetiapine, ziprasidone, and aripiprazole were not available in 1996/1997). Persons may report use of more than one medication, so sum of percents is over 100%. Figures in parentheses are linearized standard errors.
Source: Authors’ calculations from 1996−2005 Medical Expenditure Panel Survey (pooled weights).